ALCIDION GROUP LIMITED — Capital/Financing Update 2021

Dec 7, 2021

==> picture [167 x 43] intentionally omitted <==

8 December 2021

Australian Securities Exchange 20 Bridge Street, Sydney NSW 2000

Successful Completion of Placement and Institutional Entitlement Offer

Melbourne, Australia – Alcidion Group Limited ( Alcidion or the Company ) is pleased to announce that, further to its ASX announcement dated 7 December 2021, the Company has now successfully completed its institutional placement ( Placement ) and the accelerated institutional component of its nonrenounceable entitlement offer ( Institutional Entitlement Offer ). The Placement and Institutional Entitlement Offer shares will be issued at $0.25 (25 cents) per share.

The Placement raised $30 million through the issue of approximately 120 million new shares and the Institutional Entitlement Offer raised approximately $13.4 million through the issue of approximately 53 million new shares. The capital raised will be used to fund the acquisition of Silverlink.

Kate Quirke, Alcidion Managing Director, has subscribed for 1,000,000 shares ($250,000) in the Institutional Entitlement Offer. Alcidion Non-Executive Directors, Rebecca Wilson, Daniel Sharp and Simon Chamberlain intend to subscribe for their full entitlement in the Retail Entitlement Offer.

Alcidion’s Managing Director, Kate Quirke commented, “We are pleased to have successfully completed the institutional placement and accelerated institutional component of the non-renounceable entitlement offer. We are grateful for the continued support of our key existing investors, and we welcome a number of new shareholders onto our register”.

New shares issued under the Placement and Institutional Entitlement Offer are expected to settle on Tuesday, 14 December 2021 and will be issued and commence trading on the following business day, Wednesday, 15 December 2021. These shares issued will rank equally with existing Alcidion shares from their date of issue.

Alcidion shares are expected to resume trading on the ASX from market open tomorrow (Thursday, 9 December 2021).

The Retail Entitlement Offer, as referred to in the Company’s ASX announcement dated 7 December 2021, will open at 10:00am (Sydney time) on Tuesday, 14 December 2021 and close at 5:00pm (Sydney time) on Thursday, 23 December 2021.

This announcement is authorised for release by the Board of Directors of Alcidion Group Limited.

-- ENDS --

For further information, please contact:

Kerstin Wahlqvist Investor Relations Manager Alcidion Ph: +61 402 088 303 kerstin.wahlqvist@alcidion.com

Alcidion Group Limited | Level 10 9 Yarra Street SOUTH YARRA VIC 3141 |+61 3 8060 6177 | www.alcidion.com

==> picture [110 x 30] intentionally omitted <==

About Alcidion Group Limited (ASX:ALC)

Alcidion Group Limited (Alcidion) has a simple purpose: to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia and New Zealand to now service over 300 hospitals and 60 healthcare organisations, with further geographical expansion planned.

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

www.alcidion.com

Page 2